Clinical trial
Drug Use Investigation of Xofigo, Castration Resistant Prostate Cancer With Bone Metastases
NCT02803437 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Drug Use Investigation of Xofigo, Castration Resistant Prostate Cancer With Bone Metastases
- Lead sponsor
- Bayer
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 21, 2016
- Completion date
- December 18, 2024
- Enrollment
- 334 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.